When science took another step.

THESYBIN
Biotechnology designed with health in mind.

Polish technology. Protected Polish inventions. An innovative formula.

A liquid food supplement for daily use.

Science. Fermentation. Biotechnology. One Health.

Three bottles of THESYBIN food supplement
A bottle of THESYBIN food supplement

THESYBIN

THESYBIN contains OLINATI.MED® — a fermented strain of Limosilactobacillus reuteri DSM 15693, with added zinc and vitamin B5.

6.5 ml a day · 195 ml = 30 portions

  • Zinc — supports the normal function of the immune system and cognitive function.
  • Vitamin B5 — supports energy metabolism and reduces the feeling of tiredness.

claims in line with the EU register of health claims

Who should reach for Thesybin?

Some days are harder than others — more duties, less time to recover, the change of season in autumn. This is when it matters most what you consciously add to your diet. Choose ingredients with a defined, confirmed effect, not random solutions.

This is not a promise of a miracle. It is a daily habit based on technology, not on fashion.

Thesybin is a food supplement, not a medicinal product.

We start with a microorganism

A lactic acid fermentation bacterium — Limosilactobacillus reuteri DSM 15693.

It is not only about what is inside the Thesybin bottle. These things also matter:

  • which microorganism is the source of the technology,
  • how its fermentation-based biosynthesis works,
  • what material this process creates,
  • how this potential can be turned into specific uses — today and in the future.
Dishes with microorganism cultures in a laboratory

From strain to product

Four stages. One technology.

  1. Strain

    Limosilactobacillus reuteri DSM 15693

  2. Biosynthesis

    A controlled fermentation process, carried out under monitored conditions

  3. Analysis

    We check what material was created — we define its composition and properties

  4. Formulation

    We combine the tested material with zinc and vitamin B5 — this is how THESYBIN is made.

The diagram is simple. The technology behind it is not.

Science

There is knowledge behind the product.

We develop the Thesybin technology based on research into the strain, the fermentation process and the materials that this process creates.

Study / publication 01

In a six-month study, researchers built an animal model. In this model, researchers could observe the link between giving L. reuteri DSM 15693 and changes in markers related to nervous system function and behaviour. The live strain, its inactivated form and the metabolites were all linked with changes in the GFAP and S-100B markers and in the animals’ behaviour. The results point to a neuroprotective mechanism that involves astrocyte activity and the function of the nervous system. All three forms gave similar effects. This suggests that products of bacterial metabolism play a role in the observed changes. The study was preclinical and included observations of laboratory animals. However, it showed a biological model of how the bacteria and the products of their metabolism work.

The results do not justify assuming that the same changes in the levels of the studied markers will occur in humans. They also do not justify linking such an effect to the current THESYBIN formulation.

Study / publication 02

In a study on mice, researchers built a model of acute Helicobacter pylori infection, which is linked with the development of stomach and duodenal ulcer disease. The aim was to check how the presence of live L. reuteri DSM 15693 affects the stomach environment and the course of the infection. The presence of these bacteria was linked with a thicker stomach lining, a thicker layer of protective mucus and fewer gastrin-producing G cells. This may have limited the conditions that help H. pylori colonise the stomach.

The results are part of the history of research on the strain. They cannot be presented as a confirmed effect of the finished Thesybin product in humans.

Intellectual property

The technology has its history.

Patents protect the solutions related to the strain, the materials obtained in the fermentation process and their uses. The strain is deposited in the DSMZ collection under the Budapest Treaty.

3 GRANTED PATENTS · EP2457575 · EP2457576 · EP2468319

According to the patent claims, the solutions used in THESYBIN fall within the scope of patent protection. The status of a food supplement does not change the scope of this protection.

One Health

One technology. Three ways to use it.

Human health

Today: THESYBIN as a food supplement for daily use. Tomorrow: new solutions based on the technology.

Animal health

Possible future uses in maintaining animal health, welfare and productivity.

Planet health

Careful, more effective use of biological resources — something we can plan, not only declare.

Human. Animal. Planet. We do not treat these areas separately — biotechnology lets us see them as parts of one system.

Cereals, seeds and vegetables on a laboratory bench

Circular economy

We design the process to use raw materials efficiently and to reduce waste.

The circular economy remains one of the directions for further development of the Thesybin Labs PSA technology. You can find the full description of this direction (including the diagram RESOURCE → BIOTECHNOLOGY → NEW VALUE) in the Technology tab.

Discover THESYBIN

Today: one product. In the future: a platform.

The current Thesybin is the first consumer product developed by Thesybin Labs PSA. It is a starting point for building a wider portfolio based on one technological core.

Today we focus on one product: THESYBIN in liquid form, dispensed with a pump. We use it to test the market, communication, price, sales channels and repeat purchases.

In the future, the technology may be developed into other formats, for example:

  • lozenges,
  • gummies,
  • travel formats (Travel Pack).

These are directions for development, not a list of products planned for launch at the same time. Each one needs separate validation of the market, formulation, scientific evidence and legal options for communication.

At the same time, the technology can be developed more widely: in biotechnology, human and animal health, agriculture and the circular economy.

Frequently asked questions

For 30 days of use.

Without a break for 3 months, then a 2-week break, and you can start again.

Yes — the fermentation process does not use a cereal-based medium.

It contains carbohydrates, but no sugar (glucose) is added — sugars are food for the bacteria in the fermentation process.

Yes, Thesybin is a fully vegan product.

Ask a doctor or pharmacist how to use it.

Find your path

From the product to the technology. From the microbiome to One Health.

People look at our Thesybin supplement in different ways. Some want answers about the composition. Others ask how Thesybin is made. Others are interested in the wider context: why it all works and where this technology is going.

A short quiz will show you which of these perspectives is closest to you.

A free email course.

Five days with Thesybin

Five short messages, one a day from Monday to Friday. You will learn how to use Thesybin correctly and how to read information about its composition. You will also learn what to pay attention to while taking a supplement, how to avoid common mistakes and how to make the supplement part of your daily routine.

Educational materials

Knowledge we want to share.

Short, free e-books about the microbiome, fermentation and the gut–brain axis — written on the basis of scientific literature.

Basket

Products
0.00 PLN
Delivery
0.00 PLN
Total
0.00 PLN
including VAT
0.00 PLN
Go to checkout Back to the product

Your basket is empty.

The shop has one product — you can add it straight away.

THESYBIN variants and prices
VariantContentsPricePurchase
1 bottle195 ml · 30 portions160 PLNPrice per litre: 820.51 PLN
3 bottles192 ml × 3 · 96 portions450 PLNPrice per litre: 781.25 PLN
Back to the product